2-Methylbutyryl-CoA: Difference between revisions
CSV import |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:2-Methylbutanoyl-CoA.png|2-Methylbutanoyl-CoA | |||
</gallery> | |||
Latest revision as of 18:46, 16 March 2025
2-Methylbutyryl-CoA is a metabolite involved in the metabolism of amino acids. It is a substrate in the metabolic pathway of isoleucine, an essential amino acid in humans.
Metabolic Pathway[edit]
2-Methylbutyryl-CoA is produced from 2-Methylbutyryl-CoA dehydrogenase, an enzyme that catalyzes the chemical reaction in the metabolism of isoleucine. This reaction is part of the larger branched-chain amino acid degradation pathway, which is responsible for the breakdown of the essential amino acids leucine, isoleucine, and valine.
The metabolic pathway of isoleucine includes several steps:
- Isoleucine is first transaminated to 2-Ketoisocaproate.
- 2-Ketoisocaproate is then reduced to 2-Methylbutyryl-CoA.
- 2-Methylbutyryl-CoA is converted to Tiglyl-CoA by the enzyme 2-Methylbutyryl-CoA dehydrogenase.
- Tiglyl-CoA is further metabolized to form acetyl-CoA, which enters the citric acid cycle.
Clinical Significance[edit]
Deficiency in the enzyme 2-Methylbutyryl-CoA dehydrogenase can lead to a buildup of 2-Methylbutyryl-CoA, resulting in 2-Methylbutyrylglycinuria, a rare metabolic disorder. Symptoms of this disorder can include developmental delay, seizures, and hypotonia.


